| Today, Mon, Nov 23, 2009 | | | Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards PR Newswire (Mon 3:05pm)
| | | 5 Top Stocks at Half Price at Motley Fool (Mon 12:25pm)
| | Sun, Nov 22, 2009 | | | Proxy-Voting Advocates Pool Resources on the Web at The Wall Street Journal Online (Sun 10:23pm)
| | | 7 Stocks That Are Swimming in Cash at Motley Fool (Sun 8:00am)
| | Sat, Nov 21, 2009 | | | Healthcare bill gains ahead of U.S. Senate test at Reuters (Sat, Nov 21)
| | | Winners, losers in U.S. Senate health bill at Reuters (Sat, Nov 21)
| | Fri, Nov 20, 2009 | | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Wall Street Transcript (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | | UPDATE - ImmunoGen licenses anti-cancer technology to Amgen at Reuters (Thu, Nov 19)
| | | ImmunoGen licenses technology to Amgen for $1M AP (Thu, Nov 19)
| | | This Stock Is a Train Wreck at Motley Fool (Thu, Nov 19)
| | | UPDATE - EU panel blocks Merck KGaA's Erbitux in lung cancer at Reuters (Thu, Nov 19)
| | | Moody's gives negative view on pharma credit AP (Thu, Nov 19)
| | | UPDATE - Healthcare stocks not unduly hurt by Senate plan at Reuters (Thu, Nov 19)
| | | Follow the Smart Money at Motley Fool (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | | Winners, losers in U.S. Senate health bill at Reuters (Wed, Nov 18)
| | | Trading Biotech Breakthroughs at CNBC (Wed, Nov 18)
| | | The Type of Stock You Should Never, Ever Buy at Motley Fool (Wed, Nov 18)
| | | Portfolio Managers' Stock Picks: Large and Small Caps at CNBC (Wed, Nov 18)
| | | These Stocks Will Burn You at Motley Fool (Wed, Nov 18)
| | | Biotech Stocks Hot Right Now, Ho-Hum in the Long Run at The Wall Street Journal Online (Wed, Nov 18)
| Add AMGN News to My Yahoo!:

| |
|